ClinicalTrials.gg
CompletedNCT07329062Updated Jan 9, 2026

Effect of Toothpastes on Oral Malodor

An interventional study of Propolis Containing Toothpaste and Probiotic containing toothpaste in Oral Malodor (Halitosis), sponsored by Çankırı Karatekin University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-09.

Sponsored by Çankırı Karatekin University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Jan 2025, registered Dec 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

This study aimed to evaluate the effects of different toothpaste formulations on oral malodor in young adults, addressing the lack of clinical evidence regarding propolis- and probiotic-containing toothpastes, which have predominantly been investigated in mouthrinse, tablet, or chewing gum formulations.

Volunteers aged 18-30 years with baseline organoleptic assessment (OA) and Breath Checker® (BC) scores >0 were randomized into four toothpaste groups: propolis-containing (Glimo Beta), probiotic-containing (Glimo Pi), phosphate-based (Glimo Gamma), and a standard fluoride toothpaste (Sensodyne). Allocation concealment was ensured using identical coded containers, and outcome assessors were blinded. After exclusions, 52 participants completed the study. Oral malodor was evaluated at baseline (T0) and Day 14 (T1) using OA, BC measurements, and self-perceived oral malodor scores.

02

Conditions studied

  • Oral Malodor (Halitosis)

Browse trials for

Keywords

  • Oral Malodor
  • Propolis
  • Probiotic toothpaste
03

In context

Halitosis

93 studies on the registry are indexed under Halitosis; 17 are open to participants now.

This study's enrollment of 52 is above the median of 45 across 79 interventional studies indexed under Halitosis.

Browse Halitosis studies →

Lead sponsor

Çankırı Karatekin University is the lead sponsor of 65 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • No systemic diseases or medications known to cause halitosis

      • No active periodontal disease requiring treatment
      • No antibiotic use within the previous month
      • No orthodontic or removable space-maintaining appliances
      • Non-smokers
      • Organoleptic score >0 and Breath-Checker® (BC) score >0 at baseline

Exclusion criteria

Exclusion Criteria:

  • Participants reporting systemic conditions, active periodontal therapy, smoking, or antibiotic usage were excluded.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
52 participants (actual)

Study arms

  • Experimental
    Propolis containing toothpaste

    Participants in this arm used propolis containing toothpaste twice daily for routine oral hygiene during the study period.

    Other: Propolis Containing Toothpaste

  • Experimental
    probiotic containing toothpaste

    Participants in this arm used probiotic containing toothpaste twice daily for routine oral hygiene during the study period.

    Other: Probiotic containing toothpaste

  • Experimental
    Phosphate-based formulation toothpaste

    Participants in this arm used phosphate-based formulation toothpaste twice daily for routine oral hygiene during the study period.

    Other: Phosphate-based formulation toothpaste

  • Experimental
    Standard fluoride

    Participants in this arm used standard fluoride containing toothpaste twice daily for routine oral hygiene during the study period.

    Other: Standard fluoride toothpaste

Interventions

  • OtherPropolis Containing Toothpaste

    Participants were instructed to brush their teeth using propolis toothpaste twice daily (morning and evening) for 14 days as part of their routine oral hygiene.

  • OtherProbiotic containing toothpaste

    Participants were instructed to brush their teeth using probiotic toothpaste twice daily (morning and evening) for 14 days as part of their routine oral hygiene.

  • OtherPhosphate-based formulation toothpaste

    Participants were instructed to brush their teeth using Phosphate-based formulation toothpaste twice daily (morning and evening) for 14 days as part of their routine oral hygiene.

  • OtherStandard fluoride toothpaste

    Participants were instructed to brush their teeth using standard fluoride toothpaste twice daily (morning and evening) for 14 days as part of their routine oral hygiene.

06

What researchers measure

Primary outcomes

  1. Change in oral malodor severity

    Oral malodor was assessed using an organoleptic scoring method and a portable breath checker device. The change in scores from baseline to the end of the intervention period was evaluated.

    Time frame: Baseline and Day 14

07

Study locations

1 site
  • Cankiri Karatekin University
    Çankırı, Merkez, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared publicly due to privacy and ethical considerations.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07329062
Lead sponsor
Çankırı Karatekin University
Responsible party
Basak Karasu (Assisstant Professor, Çankırı Karatekin University) — Principal investigator
First posted
Jan 9, 2026
Start date
Jan 30, 2025
Primary completion
Jun 30, 2025
Completion
Dec 25, 2025
Last update
Jan 9, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion